Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x100px
Organisation › Details

Hemab ApS

Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Based in the US and Denmark, Hemab is progressing a pipeline of monoclonal and bispecific antibody-based therapeutics to transform the treatment paradigm for patients with high unmet need. The company's strategic guidance, Hemab 1-2-5TM, targets the development of 5 clinical assets by 2025 to deliver long-awaited innovation for patients with Factor VII Deficiency, Bernard Soulier Syndrome, Von Willebrand Disease, Hereditary Hemorrhagic Telangiectasia (or Osler-Weber-Rendu disease), Congenital Antithrombin III Deficiency, and other serious disorders. *

 

Period Start 2019-01-01 established (s-off)
Products Industry therapeutic antibody
  Industry 2 haemostat
Persons Person Faber, Johan H. (Hemab 202012 CEO + Co-Founder)
  Person 2 Petersen, Jørgen Søberg (Novo Group 201907 Venture Partner at Novo Ventures)
     
Region Region København (Copenhagen)
  Country Denmark
  Street 3 Ole Maaløes Vej
  City 2200 København
    Address record changed: 2024-01-05
     
Basic data Employees n. a.
     
    * Document for »About Section«: Hemab ApS. (2/21/23). "Press Release: Hemab Therapeutics Announces $135M Series B Financing to Advance First Prophylactic Treatments for Underserved Bleeding and Thrombotic Disorders". Copenhagen & Boston, MA.
     
   
Record changed: 2024-02-12

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Hemab ApS


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top